Despite the price drop, BNB is seeing growing corporate adoption, with several companies announcing plans to invest hundreds ...

Windtree Therapeutics (WINT), a Nasdaq listed biotechnology company, plans to raise up to $200 million to build a treasury of ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

BNB coin price has surged following a treasury strategy announcement from Windtree Therapeutics, a Nasdaq-listed clinical-stage biotech firm.

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, for BNB Treasury.

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...